Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a funding opportunity titled "Opportunities for HIV Cure Strategies at the Time of ART Initiation," aimed at exploring innovative interventions for HIV treatment. The primary objective is to identify cure strategies that can be administered at the start of combination antiretroviral therapy (cART) or after an analytical treatment interruption (ATI), with the goal of achieving sustained treatment-free remission. This initiative supports R21 applications for exploratory research, with a maximum budget of $275,000 and a project duration of up to two years, emphasizing the importance of diversity in research teams. Interested applicants should note that the application deadline is September 7, 2026, and can find further details at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.